{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:45:14Z","timestamp":1792107914676,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/7\/1090\/2013-RHN"],"award-info":[{"award-number":["5\/7\/1090\/2013-RHN"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRPIG-2023-0000119"],"award-info":[{"award-number":["IIRPIG-2023-0000119"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00467-026-07309-3","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:27:38Z","timestamp":1778246858000},"page":"4369-4378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A systematic review of short-term outcomes in patients with anti\u2013factor H associated atypical HUS managed with plasma exchanges versus eculizumab"],"prefix":"10.1007","volume":"41","author":[{"given":"Aditi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Bindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Sellier-Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-684X","authenticated-orcid":false,"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"7309_CR1","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","volume":"400","author":"M Michael","year":"2022","unstructured":"Michael M, Bagga A, Sartain SE, Smith RJH (2022) Haemolytic uraemic syndrome. Lancet 400:1722\u20131740","journal-title":"Lancet"},{"key":"7309_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00467-022-05451-2","volume":"37","author":"R Raina","year":"2022","unstructured":"Raina R, Sethi SK, Dragon-Durey MA, Khooblall A, Sharma D, Khandelwal P, Shapiro R, Boyer O, Yap HK, Bagga A, Licht C (2022) Systematic review of atypical hemolytic uremic syndrome biomarkers. Pediatr Nephrol 37:1479\u20131493. https:\/\/doi.org\/10.1007\/s00467-022-05451-2","journal-title":"Pediatr Nephrol"},{"key":"7309_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ki.2013.373","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D, Ohri A, Kumar M, Agarwal I, Gulati S, Anand K, Vijayakumar M, Sinha R, Sethi S, Salmona M, George A, Bal V, Singh G, Dinda AK, Hari P, Rath S, Dragon-Durey MA, Bagga A, Indian HUS Registry (2014) Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Kidney Int 85:1151\u20131160. https:\/\/doi.org\/10.1038\/ki.2013.373","journal-title":"Kidney Int"},{"key":"7309_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00467-019-04233-7","volume":"34","author":"A Bagga","year":"2019","unstructured":"Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, Patnaik SK, Sinha A, Sethi S, Hari P, Dragon-Durey MA, Indian Society of Pediatric Nephrology (2019) Hemolytic uremic syndrome in a developing country: Consensus guidelines. Pediatr Nephrol 34:1465\u20131482. https:\/\/doi.org\/10.1007\/s00467-019-04233-7","journal-title":"Pediatr Nephrol"},{"key":"7309_CR5","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1007\/s00467-024-06373-x","volume":"39","author":"M Ferri","year":"2024","unstructured":"Ferri M, Zotta F, Donadelli R, Dossier C, Duneton C, El-Sissy C, Fremeau-Bacchi V, Kwon T, Quadri L, Pasini A, Sellier-Leclerc AL, Vivarelli M, Hogan J (2024) Anti-CFH-associated hemolytic uremic syndrome: Do we still need plasma exchange? Pediatr Nephrol 39:3263\u20133269. https:\/\/doi.org\/10.1007\/s00467-024-06373-x","journal-title":"Pediatr Nephrol"},{"key":"7309_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.kint.2024.09.012","volume":"106","author":"D Kavanagh","year":"2024","unstructured":"Kavanagh D, Ardissino G, Brocklebank V, Bouwmeester RN, Bagga A, Ter Heine R, Johnson S, Licht C, Ma ALT, Noris M, Praga M, Rondeau E, Sinha A, Smith RJH, Sheerin NS, Trimarchi H, Wetzels JFM, Vivarelli M, Van de Kar NCAJ, Greenbaum LA, Forum Participants (2024) Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum. Kidney Int 106:1038\u20131050. https:\/\/doi.org\/10.1016\/j.kint.2024.09.012","journal-title":"Kidney Int"},{"key":"7309_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01282","volume":"10","author":"M Puraswani","year":"2019","unstructured":"Puraswani M, Khandelwal P, Saini H, Saini S, Gurjar BS, Sinha A, Shende RP, Maiti TK, Singh AK, Kanga U, Ali U, Agarwal I, Anand K, Prasad N, Rajendran P, Sinha R, Vasudevan A, Saxena A, Agarwal S, Hari P, Sahu A, Rath S, Bagga A (2019) Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: A nationwide database. Front Immunol 10:1282","journal-title":"Front Immunol"},{"key":"7309_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.25259\/IJN_140_2025","volume":"35","author":"T Bindal","year":"2025","unstructured":"Bindal T, Sinha A, Bagga A (2025) Eculizumab for atypical hemolytic uremic syndrome: Guidance for developing countries. Indian J Nephrol 35:466\u2013475. https:\/\/doi.org\/10.25259\/IJN_140_2025","journal-title":"Indian J Nephrol"},{"key":"7309_CR9","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00467-024-06279-8","volume":"39","author":"S Thangaraju","year":"2024","unstructured":"Thangaraju S, Khandelwal P, Mishra K, Kumar M, Puraswani M, Saini R, Hari P, Coshic P, Sinha A, Bagga A (2024) Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome. Pediatr Nephrol 39:2091\u20132097. https:\/\/doi.org\/10.1007\/s00467-024-06279-8","journal-title":"Pediatr Nephrol"},{"key":"7309_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.52547\/ijkd.6507","volume":"15","author":"K Tiewsoh","year":"2021","unstructured":"Tiewsoh K, Govindarajan S, Dawman L, Rawat A, Ramachandran R, Hans R (2021) Anti-compliment factor H antibody associated hemolytic uremic syndrome in children with abbreviated plasma exchanges: A 12-month follow-up study. Iran J Kidney Dis 15:419\u2013425. https:\/\/doi.org\/10.52547\/ijkd.6507","journal-title":"Iran J Kidney Dis"},{"key":"7309_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med 18:e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"key":"7309_CR12","unstructured":"Wells GA, Wells G, Shea B, Shea B, O'Connell D, Peterson J, Welch J, Losos M, Tugwell P, Ga SW, Zello GA, Petersen JA (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 1 Jan 2026."},{"key":"7309_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.11124\/JBIES-22-00224","volume":"21","author":"Z Munn","year":"2023","unstructured":"Munn Z, Stone JC, Aromataris E, Klugar M, Sears K, Leonardi-Bee J, Barker TH (2023) Assessing the risk of bias of quantitative analytical studies: Introducing the vision for critical appraisal within JBI systematic reviews. JBI Evid Synth 21:467\u2013471. https:\/\/doi.org\/10.11124\/JBIES-22-00224","journal-title":"JBI Evid Synth"},{"key":"7309_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/jca.21711","volume":"34","author":"P Khandelwal","year":"2019","unstructured":"Khandelwal P, Thomas CC, Rathi BS, Hari P, Tiwari AN, Sinha A, Bagga A (2019) Membrane-filtration based plasma exchanges for atypical hemolytic uremic syndrome: Audit of efficacy and safety. J Clin Apher 34:555\u2013562. https:\/\/doi.org\/10.1002\/jca.21711","journal-title":"J Clin Apher"},{"key":"7309_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00467-013-2654-x","volume":"29","author":"D Noone","year":"2014","unstructured":"Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C (2014) Successful treatment of DEAP-HUS with eculizumab. Pediatr Nephrol 29:841\u2013851. https:\/\/doi.org\/10.1007\/s00467-013-2654-x","journal-title":"Pediatr Nephrol"},{"key":"7309_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/ijn.IJN_336_18","volume":"30","author":"T Kise","year":"2020","unstructured":"Kise T, Fukuyama S, Uehara M (2020) Successful treatment of anti-factor H antibody-associated atypical hemolytic uremic syndrome. Indian J Nephrol 30:35\u201338. https:\/\/doi.org\/10.4103\/ijn.IJN_336_18","journal-title":"Indian J Nephrol"},{"key":"7309_CR17","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","volume":"189","author":"C Blanc","year":"2012","unstructured":"Blanc C, Roumenina LT, Ashraf Y, Hyv\u00e4rinen S, Sethi SK, Ranchin B, Niaudet P, Loirat C, Gulati A, Bagga A, Fridman WH, Saut\u00e8s-Fridman C, Jokiranta TS, Fr\u00e9meaux-Bacchi V, Dragon-Durey MA (2012) Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome. J Immunol 189:3528\u20133537. https:\/\/doi.org\/10.4049\/jimmunol.1200679","journal-title":"J Immunol"},{"key":"7309_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40262-019-00742-8","volume":"58","author":"KL Wijnsma","year":"2019","unstructured":"Wijnsma KL, Ter Heine R, Moes DJAR, Langemeijer S, Schols SEM, Volokhina EB, van den Heuvel LP, Wetzels JFM, van de Kar NCAJ, Br\u00fcggemann RJ (2019) Pharmacology, pharmacokinetics and pharmacodynamics of eculizumab, and possibilities for an individualized approach to eculizumab. Clin Pharmacokinet 58:859\u2013874. https:\/\/doi.org\/10.1007\/s40262-019-00742-8","journal-title":"Clin Pharmacokinet"},{"key":"7309_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C (2016) Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int 89:701\u2013711. https:\/\/doi.org\/10.1016\/j.kint.2015.11.026","journal-title":"Kidney Int"},{"key":"7309_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","volume":"68","author":"F Fakhouri","year":"2016","unstructured":"Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Prov\u00f4t F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM (2016) Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: A single-arm, open-label trial. Am J Kidney Dis 68:84\u201393. https:\/\/doi.org\/10.1053\/j.ajkd.2015.12.034","journal-title":"Am J Kidney Dis"},{"key":"7309_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","volume":"29","author":"S Johnson","year":"2014","unstructured":"Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM (2014) An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol 29:1967\u20131978. https:\/\/doi.org\/10.1007\/s00467-014-2817-4","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07309-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:54:20Z","timestamp":1792104860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07309-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["7309"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07309-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}